Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Drug Targets. Inflammation and Allergy
|
December 9, 2004
Interactions of sex steroids with mechanisms of inflammation
Maik Obendorf, Vladimir K Patchev
Dialogues in Clinical Neuroscience
|
February 13, 2007
Experimental models of stress
Vladimir K Patchev, Alexandre V Patchev
Archives of Biochemistry and Biophysics
|
March 14, 2007
A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR
Siegmund S Wolf, Vladimir K Patchev, Maik Obendorf
Experimental Gerontology
|
December 8, 2004
Neurotropic action of androgens: principles, mechanisms and novel targets
Vladimir K Patchev, Jens Schroeder, Franziska Goetz, et al.
Drug Discovery Today
|
July 22, 2008
Neurotrophic estrogens: essential profile and endpoints for drug discovery
Vladimir K Patchev, Sergey O Bachurin, Michael Albers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 29, 2003
Developmental expression profiles and distinct regional estrogen responsiveness suggest a novel role for the steroid receptor coactivator SRC-1 as discriminative amplifier of estrogen signaling in the rat brain
Yuri A Mitev, Siegmund S Wolf, Osborne F X Almeida, et al.
Menopause (New York, N.Y.)
|
April 5, 2012
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease
Katja Prelle, Bernd-Wolfgang Igl, Maik Obendorf, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 8, 2007
FoxG1, a member of the forkhead family, is a corepressor of the androgen receptor
Maik Obendorf, Rene Meyer, Konstanze Henning, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 1, 2006
Insidious adrenocortical insufficiency underlies neuroendocrine dysregulation in TIF-2 deficient mice
Alexandre V Patchev, Dieter Fischer, Siegmund S Wolf, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Drug Targets. Inflammation and Allergy
|
December 9, 2004
Interactions of sex steroids with mechanisms of inflammation
Maik Obendorf, Vladimir K Patchev
Dialogues in Clinical Neuroscience
|
February 13, 2007
Experimental models of stress
Vladimir K Patchev, Alexandre V Patchev
Archives of Biochemistry and Biophysics
|
March 14, 2007
A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR
Siegmund S Wolf, Vladimir K Patchev, Maik Obendorf
Experimental Gerontology
|
December 8, 2004
Neurotropic action of androgens: principles, mechanisms and novel targets
Vladimir K Patchev, Jens Schroeder, Franziska Goetz, et al.
Drug Discovery Today
|
July 22, 2008
Neurotrophic estrogens: essential profile and endpoints for drug discovery
Vladimir K Patchev, Sergey O Bachurin, Michael Albers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 29, 2003
Developmental expression profiles and distinct regional estrogen responsiveness suggest a novel role for the steroid receptor coactivator SRC-1 as discriminative amplifier of estrogen signaling in the rat brain
Yuri A Mitev, Siegmund S Wolf, Osborne F X Almeida, et al.
Menopause (New York, N.Y.)
|
April 5, 2012
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease
Katja Prelle, Bernd-Wolfgang Igl, Maik Obendorf, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 8, 2007
FoxG1, a member of the forkhead family, is a corepressor of the androgen receptor
Maik Obendorf, Rene Meyer, Konstanze Henning, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 1, 2006
Insidious adrenocortical insufficiency underlies neuroendocrine dysregulation in TIF-2 deficient mice
Alexandre V Patchev, Dieter Fischer, Siegmund S Wolf, et al.
Page
of 1